These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 776862)
1. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test. Job CK; Chacko CJ; Taylor PM; Daniel M; Jesudian G Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862 [TBL] [Abstract][Full Text] [Related]
2. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ; Closs O; Belehu A Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003 [TBL] [Abstract][Full Text] [Related]
3. Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD. Smelt AH; Liew FY; Rees RJ Clin Exp Immunol; 1978 Nov; 34(2):164-9. PubMed ID: 367652 [TBL] [Abstract][Full Text] [Related]
4. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation. Bjune G Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309 [TBL] [Abstract][Full Text] [Related]
5. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Brett SJ; Kingston AE; Colston MJ Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217 [TBL] [Abstract][Full Text] [Related]
6. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181 [TBL] [Abstract][Full Text] [Related]
7. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients. Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125 [TBL] [Abstract][Full Text] [Related]
8. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
9. Correlation of clinical, histological and immunological features across the leprosy spectrum. Narayan NP; Ramu G; Desikan KV; Vallishayee RS Indian J Lepr; 2001; 73(4):329-42. PubMed ID: 11898465 [TBL] [Abstract][Full Text] [Related]
10. A placebo controlled clinical trial of transfer factor in lepromatous leprosy. Faber WR; Leiker DL; Nengerman IM; Schellekens PT Clin Exp Immunol; 1979 Jan; 35(1):45-52. PubMed ID: 371887 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules. Bapat CV; Modak MS; DeSouza NG; Chulawalla RG Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823 [TBL] [Abstract][Full Text] [Related]
12. Lymphocyte transformation test in healthy contacts of patients with leprosy. I. Influence of exposure to leprosy within a household. Menzel S; Bjune G; Kronvall G Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):138-52. PubMed ID: 378871 [TBL] [Abstract][Full Text] [Related]
13. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193 [TBL] [Abstract][Full Text] [Related]
14. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278 [TBL] [Abstract][Full Text] [Related]
15. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2. Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366 [TBL] [Abstract][Full Text] [Related]
16. Cellular immune responses to mycobacterial heat shock proteins in Nepali leprosy patients and controls. Roche PW; Theuvenet WJ; Britton WJ Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):36-43. PubMed ID: 1602192 [TBL] [Abstract][Full Text] [Related]
17. A study of the immunological effects of cimetidine in patients with lepromatous leprosy. Brown AE; Nelson KE; Makonkawkeyoon S; Vithayasai V; Scollard DM; Bullock WE Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):559-64. PubMed ID: 3910745 [TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953 [TBL] [Abstract][Full Text] [Related]
19. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Myrvang B; Godal T; Ridley DS; Fröland SS; Song YK Clin Exp Immunol; 1973 Aug; 14(4):541-53. PubMed ID: 4583777 [TBL] [Abstract][Full Text] [Related]
20. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy. Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]